Time to rethink high-density lipoprotein?
Wild
Sarah
S
Byrne
Christopher D
CD
D000924:Anticholesteremic Agents / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D008075:Lipoproteins, HDL / Q000378:metabolism*; D011804:Quinolines / Q000009:adverse effects; D040242:Risk Reduction Behavior
D000924:Anticholesteremic Agents; D008075:Lipoproteins, HDL; D011804:Quinolines; C483909:torcetrapib